BNP Paribas Financial Markets’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-77,784
| Closed | -$3.08M | – | 4244 |
|
|
2024
Q1 | $3.08M | Sell |
77,784
-29,157
| -27% | -$860K | ﹤0.01% | 1782 |
|
|
2023
Q4 | $2.04M | Buy |
106,941
+93,423
| +691% | +$1.3M | ﹤0.01% | 1947 |
|
|
2023
Q3 | $155K | Buy |
13,518
+5,029
| +59% | +$61.9K | ﹤0.01% | 3190 |
|
|
2023
Q2 | $87.3K | Sell |
8,489
-12,029
| -59% | -$108K | ﹤0.01% | 3296 |
|
|
2023
Q1 | $158K | Buy |
20,518
+5,007
| +32% | +$39.9K | ﹤0.01% | 3219 |
|
|
2022
Q4 | $114K | Buy |
15,511
+8,939
| +136% | +$57.1K | ﹤0.01% | 3214 |
|
|
2022
Q3 | $47.3K | Buy |
6,572
+3,090
| +89% | +$25.5K | ﹤0.01% | 3990 |
|
|
2022
Q2 | $29.6K | Sell |
3,482
-295
| -8% | -$2.54K | ﹤0.01% | 3655 |
|
|
2022
Q1 | $33.9K | Buy |
3,777
+531
| +16% | +$4.59K | ﹤0.01% | 3632 |
|
|
2021
Q4 | $45K | Buy |
3,246
+1,130
| +53% | +$14K | ﹤0.01% | 3759 |
|
|
2021
Q3 | $22.6K | Buy |
2,116
+1,668
| +372% | +$15.4K | ﹤0.01% | 3625 |
|
|
2021
Q2 | $4.03K | Buy |
+448
| New | +$4.87K | ﹤0.01% | 3819 |
|
|
2016
Q1 | – | Sell |
-214
| Closed | -$6.63K | – | 3142 |
|
|
2015
Q4 | $6.63K | Sell |
214
-19
| -8% | -$649 | ﹤0.01% | 3436 |
|
|
2015
Q3 | $12.1K | Buy |
+233
| New | +$15.3K | ﹤0.01% | 3407 |
|
BNP Paribas Financial Markets's ALPN Position: Q2 2024 in Review
BNP Paribas Financial Markets sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 77,784 shares — an estimated $3.08M sold.
BNP Paribas Financial Markets first reported a position in ALPN in Q3 2015 and held it in 14 quarters. The position peaked at $3.08M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- BNP Paribas Financial Markets reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- BNP Paribas Financial Markets sold 77,784 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $3.08M.
- BNP Paribas Financial Markets first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 14 quarters.
- BNP Paribas Financial Markets's Alpine Immune Sciences Inc position peaked at $3.08M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2024, filed 13 Aug 2024.